This was LIDE's first time exhibiting at the American Association of Pharmaceutical Scientists (AAPS) PharmSci360, held at the BCEC in Boston this year, October 16-19, 2022.
News & Events
LIDE was happy to sponsor and attend the first @Philly Cell and Gene Therapy 2022 Annual Conference, hosted by the American Chinese Medicine Association-Greater Philadelphia Chapter (SAPA-GP) on June 17-18, 2022.
LIDE Biotech was excited to be live at this year's American Association of Cancer Research (AACR) Annual Meeting in New Orleans, April 8-13, 2022. We appreciated connecting with everyone in New Orleans, shared our four poster presentations and met with lots of scientists at booth #2057.
In September 2021, Shanghai LIDE's patented product MiniPDX won the 2021 IQ Association and AAALAC International Animal Research Global 3Rs Award. As one of the researchers of MiniPDX, Dr. Wenjie Wang from Shanghai LIDE medical department won the award on behalf of Shanghai LIDE.
During the hot summer, entire LIDE staff came to Wuzhen with its beautiful landscape for a company-wide team building. This occasion marked the 10 year anniversary of the company, celebrating our many successes and reflection on the challenges to get there. The entire staff enjoyed both relaxation and walking down memory lane.
On June 25 to 26, 2021 the 4th China BIO-PHARM Innovation and Cooperation Conference (BIO-PHARM 2021) came to a successful conclusion in Suzhou, China. One of the forum, “New Drug Clinical Research and Digital Management”, was hosted by Dr. Danyi Wen, President & CEO of LIDE Biotech. She carries a high reputation in the biomedical industry and presented unique insights in clinical research of new drugs.
Professor Hans Clevers is an international pioneer in the research field of "Organoid". He is very impressed by LIDE’s innovated application of organoid assay. In his review articles, Professor Clevers foresaw some potential applications of three major functional diagnosis assays: Conditional Reprogrammed Cells, Organoid and PDX. Professor Clevers was happy to see that LIDE put his prediction into real practice.